Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.59 |
| ▸ | LMNA | P02545 | 3/20 | 0.58 |
| ▸ | HTT | P42858 | 2/20 | 0.58 |
| ▸ | POLB | P06746 | 2/20 | 0.58 |
| ▸ | MAPT | P10636 | 3/20 | 0.57 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.56 |
| ▸ | NPC1 | O15118 | 1/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.53 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.53 |
| ▸ | PRKDC | P78527 | 1/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.53 |
| ▸ | CASP3 | P42574 | 1/20 | 0.52 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.52 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.52 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.52 |
| ▸ | PKM | P14618 | 1/20 | 0.51 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | GAA | P10253 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30716507 | 1.00 | L3MBTL1 (0.59) | L3MBTL1LMNAHTTPOLBMAPT | |
| SCHEMBL9908175 | 0.92 | L3MBTL1 (0.53) | L3MBTL1LMNAHTTPOLBMAPT | |
| SCHEMBL25362735 | 0.89 | L3MBTL1 (0.51) | L3MBTL1LMNAHTTPOLBMAPT | |
| SCHEMBL7521404 | 0.89 | HTT (0.56) | L3MBTL1LMNAHTTPOLBMAPT | |
| SCHEMBL19514652 | 0.88 | L3MBTL1 (0.49) | L3MBTL1LMNAHTTPOLBMAPT | |
| SCHEMBL9908176 | 0.88 | HTT (0.54) | L3MBTL1LMNAHTTPOLBMAPT | |
| SCHEMBL12779095 | 0.88 | L3MBTL1 (0.49) | L3MBTL1LMNAHTTPOLBMAPT | |
| SCHEMBL21753420 | 0.88 | POLB (0.52) | L3MBTL1LMNAHTTPOLBMAPT | |
| SCHEMBL15275125 | 0.88 | LMNA (0.52) | L3MBTL1LMNAHTTPOLBMAPT | |
| SCHEMBL2605630 | 0.87 | LMNA (0.73) | L3MBTL1LMNAHTTPOLBMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 82 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4703409-A1 | LIGHT-RESPONSIVE CELL DESIGNER MOLECULE | The University of Osaka (JP) | 2026-03-04 | — | — | EP | claimed |
| WO-2024225384-A1 | LIGHT-RESPONSIVE CELL DESIGNER MOLECULE | 国立大学法人大阪大学 | 2024-10-31 | — | — | WO | claimed |
| CN-102532116-B | Synthesis method of anti-tumor targeted therapeutic drug tivozanib | WUHAN MAIDESEN MEDICAL TECHNOLOGY CO LTD | 2015-01-21 | — | — | CN | claimed |
| CN-102532116-A | Synthesis method of anti-tumor targeted therapeutic drug tivozanib | WUHAN MAIDESEN MEDICAL TECHNOLOGY CO LTD | 2012-07-04 | — | — | CN | claimed |
| EP-4703409-A1 | LIGHT-RESPONSIVE CELL DESIGNER MOLECULE | The University of Osaka (JP) | 2026-03-04 | — | — | EP | disclosed |
| WO-2025133603-A1 | LIQUID-PHASE PROCESS FOR PREPARING OLIGONUCLEOTIDES | Exactmer Limited (GB) | 2025-06-26 | — | — | WO | disclosed |
| WO-2024225384-A1 | LIGHT-RESPONSIVE CELL DESIGNER MOLECULE | 国立大学法人大阪大学 | 2024-10-31 | — | — | WO | disclosed |
| US-20240201575-A1 | PHOTOSENSITIVE SURFACE TREATMENT AGENT, LAMINATE, TRANSISTOR, METHOD FOR FORMING PATTERN AND METHOD FOR MANUFACTURING TRANSISTOR | NIKON CORPORATION (JP) | 2024-06-20 | — | — | US | disclosed |
| CN-118146194-A | Novel quinoline compound containing 6-oxo-1-substituted phenyl-1, 6-dihydropyridazine-3-carboxamide and application thereof | 辽宁大学 | 2024-06-07 | — | — | CN | disclosed |
| CN-117813550-A | Photosensitive surface treating agent, laminate, transistor, pattern forming method, and method for manufacturing transistor | 株式会社尼康 | 2024-04-02 | — | — | CN | disclosed |
| CN-117402143-A | EGFR inhibitor and preparation and application thereof | 上海翰森生物医药科技有限公司 | 2024-01-16 | — | — | CN | disclosed |
| CN-117343046-A | Novel 3-oxo-4-substituted aryl-3, 4-dihydropyrazine-2-carboxamide compound and application thereof | 辽宁大学 | 2024-01-05 | — | — | CN | disclosed |
| US-6171756-B1 | SOLVENT SOLUBLE ORGANIC PHOTOPRECURSORS OF AMINES FOR USE IN PHOTOSENSITIVE IMAGING SYSTEMS, SAID PHOTOPRECURSORS GENERATING FREE AMINES ON EXPOSURE TO LONG WAVELENGTH UV OR VISIBLE RADIATION, COMPRISING PHOTOLABILE 2-NITROBENZYL GROUPS | AFGA-GEVAERT, N.V. (BE) | 2001-01-09 | — | — | US | disclosed |
| US-6017758-A | DMNPE caged nucleic acid and vector | VANDERBILT UNIVERSITY (US) | 2000-01-25 | — | — | US | disclosed |
| EP-0926555-A1 | Photoactive materials applicable to imaging systems. | AGFA-GEVAERT N.V. (BE) | 1999-06-30 | — | — | EP | disclosed |
| US-5888829-A | Photolabile caged ionophores and method of using in a membrane separation process | MOLECULAR PROBES, INC. (US) | 1999-03-30 | — | — | US | disclosed |
| EP-0107398-B1 | ORTHO SUBSTITUTED DIHYDROXY-2(1H)QUINAZOLINONE-1-ALKANOIC ACIDS | ORTHO PHARMA CORP (US) | 1988-06-08 | — | — | EP | disclosed |
| US-4631283-A | RENAL VASODILATORS, CARDIOVASCULAR AGENTS | ORTHO PHARMACEUTICAL CORPORATION (US) | 1986-12-23 | — | — | US | disclosed |
| US-4490374-A | CARDIOVASCULAR AGENTS | ORTHO PHARMACEUTICAL CORPORATION (US) | 1984-12-25 | — | — | US | disclosed |
| EP-0107398-A1 | Ortho substituted dihydroxy-2(1H)quinazolinone-1-alkanoic acids | ORTHO PHARMACEUTICAL CORPORATION (US) | 1984-05-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240201575-A1 | PHOTOSENSITIVE SURFACE TREATMENT AGENT, LAMINATE, TRANSISTOR, METHOD FOR FORMING PATTERN AND METHOD FOR MANUFACTURING TRANSISTOR | CDH1, DSG1, KRT18 | L3MBTL1 4161/4885LMNA 673/4885HTT 3252/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.